|
||
| |
Home | Articles | Product Information | |
|
|
Dose-dependent inhibition of large intestinal cancer by inositol hexaphosphate in F344 rats. Author(s): Ullah-A, Shamsuddin-A-M. Source: Carcinogenesis 1990 Dec, VOL: 11 (12), P: 2219-22, ISSN: 0143-3334. Abstract: We have previously reported that inositol hexaphosphate (InsP6) inhibits
mitosis and large intestinal cancer (LIC) in F344 rats and CD1 mice
when given as 1 or 2% solution in drinking water at the unadjusted pH
of 11.3. The purpose of this study was to determine whether InsP6 (i)
shows a dose-response inhibition of LIC, and (ii) retains its anti-neoplastic
effect at physiological pH. Since InsP6 is known to be a chelator of
divalent cations, in preparation for putative clinical trials in humans,
we also looked at the mineral bioavailability. F344 rats were fed 0.1%
(pH 10.8), 1% (pH 11.3) and 1% (pH 7.4) Na-InsP6 in drinking water.
Two weeks following the beginning of InsP6 supplementation, rats were
given six injections of azoxymethane (AOM) at a dose of 8 mg/kg body
wt/week and were killed 30 weeks following the last injection. Compared
to the untreated control rats injected with AOM, 1% InsP6 (pH 11.3)
reduces tumor prevalence by 52.2% (P less than 0.01), tumor frequency
by 55.8% (P = 0.001) and tumor size by 62.3% (P = 0.001); 0.1% InsP6
showed a lesser reduction in tumor prevalence (21%) but a greater reduction
in tumor size 71% (P = 0.001). While there was no significant difference
in tumor prevalence and frequency between the two pH groups, the tumor
size following 1% InsP6 (pH 7.4) was the smallest (65% smaller than
those of pH 11.3, P less than 0.005). There was no significant difference
in the serum Mg2+, Ca2+, Fe2+ and Zn2+ level between control rats and
those treated with 1% InsP6. We therefore demonstrate that InsP6 (i)
is consistently anti-neoplastic for LIC in a dose-dependent manner,
(ii) retains its anti-neoplastic activity at physiological pH and (iii)
has no demonstrable toxic effect on long- term administration as evident
by body wt data and serum mineral levels.
-- Return to Articles |
| |
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. | |